Phase II trial of gefitinib inpatients with incurable salivary gland cancer.

被引：0
|
作者：
Glisson, BS [1 ]
Blumenschein, G [1 ]
Francisco, M [1 ]
Erasmus, J [1 ]
Zinner, R [1 ]
Kies, M [1 ]
机构：
[1] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：508S / 508S
页数：1
相关论文
共 50 条
  • [21] Nivolumab plus ipilimumab in advanced salivary gland cancer: a phase 2 trial
    Joris L. Vos
    Bharat Burman
    Swati Jain
    Conall W. R. Fitzgerald
    Eric J. Sherman
    Lara A. Dunn
    James V. Fetten
    Loren S. Michel
    Anuja Kriplani
    Kenneth K. Ng
    Juliana Eng
    Vatche Tchekmedyian
    Sofia Haque
    Nora Katabi
    Fengshen Kuo
    Catherine Y. Han
    Zaineb Nadeem
    Wei Yang
    Vladimir Makarov
    Raghvendra M. Srivastava
    Irina Ostrovnaya
    Manu Prasad
    Charlotte L. Zuur
    Nadeem Riaz
    David G. Pfister
    Christopher A. Klebanoff
    Timothy A. Chan
    Alan L. Ho
    Luc G. T. Morris
    Nature Medicine, 2023, 29 : 3077 - 3089
  • [22] A phase II trial of gefitinib for recurrent or metastatic cancer of the esophagus or gastroesophageal junction
    David J. Adelstein
    Cristina P. Rodriguez
    Lisa A. Rybicki
    Denise I. Ives
    Thomas W. Rice
    Investigational New Drugs, 2012, 30 : 1684 - 1689
  • [23] A phase II trial of gefitinib for recurrent or metastatic cancer of the esophagus or gastroesophageal junction
    Adelstein, David J.
    Rodriguez, Cristina P.
    Rybicki, Lisa A.
    Ives, Denise I.
    Rice, Thomas W.
    INVESTIGATIONAL NEW DRUGS, 2012, 30 (04) : 1684 - 1689
  • [24] Phase I/II trial of gefitinib and oxaliplatin in patients with advanced colorectal cancer
    Kindler, HL
    Friberg, G
    Skoog, L
    Wade-Oliver, K
    Vokes, EE
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2005, 28 (04): : 340 - 344
  • [25] A phase II trial of pemetrexed in previously untreated breast cancer.
    Gomez, H
    Hanauske, AR
    Santillana, S
    Vallejos, C
    Paoletti, P
    Robb, C
    Lee, D
    Penn, K
    Hockett, R
    Chen, V
    Niyikiza, C
    BREAST CANCER RESEARCH AND TREATMENT, 2002, 76 : S66 - S66
  • [26] Phase II trial of sorafenib in patients with advanced thyroid cancer.
    Keefe, S. M.
    Troxel, A. B.
    Rhee, S.
    Puttaswamy, K.
    O'Dwyer, P. J.
    Loevner, L. A.
    Mandel, S. J.
    Brose, M. S.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [27] A phase II trial of gemcitabine and celecoxib for metastatic pancreatic cancer.
    Xiong, HQ
    Hess, KR
    Kayaleh, OR
    Goodwin, JW
    Banerjee, T
    Sinclair, SS
    Fisch, MJ
    Wolff, RA
    Abbruzzese, JL
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 351S - 351S
  • [28] Delta tocotrienol in recurrent ovarian cancer. A phase II trial
    Thomsen, Caroline Brenner
    Andersen, Rikke Fredslund
    Steffensen, Karina Dahl
    Adimi, Parvin
    Jakobsen, Anders
    PHARMACOLOGICAL RESEARCH, 2019, 141 : 392 - 396
  • [29] Phase II trial of first-line gefitinib in patients unsuitable for chemotherapy with stage II/IV non-small-cell lung cancer.
    Swinson, D
    Williams, S
    Beddard, K
    Price, L
    Reaper, L
    Cullen, MH
    Ferry, DR
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 684S - 684S
  • [30] A Phase II Trial of Pembrolizumab and Vorinostat in Recurrent Metastatic Head and Neck Squamous Cell Carcinomas and Salivary Gland Cancer
    Rodriguez, Cristina P.
    Wu, Qian
    Voutsinas, Jenna
    Fromm, Jonathan R.
    Jiang, Xiuyun
    Pillarisetty, Venu G.
    Lee, Sylvia M.
    Santana-Davila, Rafael
    Goulart, Bernardo
    Baik, Christina S.
    Chow, Laura Q. M.
    Eaton, Keith
    Martins, Renato
    CLINICAL CANCER RESEARCH, 2020, 26 (04) : 837 - 845
12345